While HIPAA rules protect health information of patients in hospitals and for physician visits, generally they do not protect the privacy or security of a patient’s health and wellness information when it is created accessed through or stored on personal cell …

Sep 8, 2023 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...

Sep 1, 2023 · What Are Other Causes of Gastroparesis? Diabetes is the most common underlying cause of gastroparesis and can damage the vagus nerve, leading to impaired muscular function in the stomach and small intestine. 3 Studies show that the 10-year cumulative incidence of diabetic gastroparesis is estimated to be 5.2% among patients with type 1 diabetes and 1% in patients with type 2 diabetes. 4

Jan 7, 2020 · Patients with gastroesophageal reflux disease (GERD) are frequently referred to gastroenterologists. As patients get older GERD is more common, with a prevalence of 20% or higher in the outpatient setting. 1 Elderly patients with GERD can clinically present differently than younger patients and their management may therefore vary. A review article published by Dr M Kurin of the Digestive ...

Oct 11, 2024 · Clarithromycin administered via a dispersible tablet has a higher Helicobacter pylori (H pylori) eradication rate than clarithromycin sustained-release tablets, according to study results published in Therapeutic Advances in Gastroenterology.

Aug 19, 2022 · The American College of Gastroenterology (ACG) released updated clinical guidelines on managing gastroparesis (GP). The new recommendations were published in The American Journal of Gastroenterology.. GP is characterized by delayed gastric emptying (GE) of solid food in the absence of mechanical obstruction.

Sep 27, 2024 · Over the summer, the US Food and Drug Administration (FDA) approved a biosimilar for Crohn disease (CD) and ulcerative colitis (UC), a blood-based test for colorectal cancer (CRC) screening, a new indication for heartburn associated with nonerosive gastroesophageal reflux disease (GERD), a new indication for UC, and a new indication for younger patients with progressive familial intrahepatic ...

While HIPAA rules protect health information of patients in hospitals and for physician visits, generally they do not protect the privacy or security of a patient’s health and wellness information when it is created accessed through or stored on personal cell …

Oct 25, 2024 · The American Gastroenterological Association (AGA) has released a clinical practice update for managing upper gastrointestinal (GI) tract disorders with potassium-competitive acid blockers (P-CABs).

Aug 30, 2024 · Risk Assessment. For adults with complicated IAI, the panel recommends the APACHE II (Acute Physiology Age Chronic Health Evaluation II) as the preferred measurement scale for risk stratification within 24 hours of hospital or intensive care unit (ICU) admission (low certainty of evidence).